Teva Goes After Mylan Over Copaxone Patents
Teva Pharmaceutical Industries Ltd. has accused Mylan Pharmaceuticals Inc. of infringing four patents related to the characterization of multiple sclerosis treatment Copaxone....To view the full article, register now.
Already a subscriber? Click here to view full article